|
Market Cap (7-Jul) $981,203,648 (700th) |
Close (30-Jun) $0.70 |
Volume (30-Jun) 56,305 |
Shortsold (26-May) 28,715,960 (7.70%) (37th) |
|
52w High $5.87 |
52w Low $1.80 |
P/E - |
EPS -0.28 |
A news article has been posted about Clarity Pharmaceuticals on the AFR. The article was published around , on 9 February 2023 at 2:59pm.
Debt-laden GenesisCare has sold its 6 per cent stake in biotech small cap Clarity Pharmaceuticals via Wilsons’ equities desk. Clarity Pharmaceuticals executive chairman Alan Taylor’s likely to have some new faces on his share register following ...
Read ArticleCU6 was $0.83 at the close of trade on 08 February 2023
| Recent Articles about ASX:CU6 | |
|---|---|
| 27-Dec | ASX rises on post Christmas trading
msn.com |
| 27-Dec | Clarity Pharmaceuticals Ltd (CU6)
au.investing.com |
| 20-Dec | Hot Stocks: Exosome Breakthrough, Gas Pipeline Deals and More
sharecafe.com.au |
| 20-Dec | Clarity Pharmaceuticals Ltd CU6
morningstar.com |
| 19-Dec | Clarity Pharmaceuticals develops novel FAP-targeted radiopharmaceutical
bioworld.com |
| 19-Dec | Clarity expands its pipeline with a novel optimised FAP-targeted radiopharmaceutical
vietreader.com |
| 18-Dec | Clarity Pharmaceuticals (ASX:CU6) Launches New Cancer Radiopharmaceutical
kalkinemedia.com |
| 18-Dec | Clarity Expands Its Pipeline With A Novel Optimised FAP-Targeted Radiopharmaceutical
menafn.com |
| 18-Dec | Clarity Pharmaceuticals Lists New Securities on ASX
markets.businessinsider.com |
| 18-Dec | Why Clarity, Omni Bridgeway, Santana Minerals, and Vulcan shares are pushing higher today
msn.com |
| Tracked |
Find all articles about Clarity Pharmaceuticals, including others on the AFR, on the media page.
You must be logged in to post a reply.
